Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President, Representative Director: Gyo Sagara, “ONO”) announced that it continues to be selected for ESG (Environmental, Social, and Governance) investment indices provided by MSCI, FTSE Russell and S&P Dow Jones Indices.

<MSCI Inc.>

• -MSCI Japan ESG Select Leaders Index (4 consecutive years from 2019)

  Among the component companies of the MSCI Japan IMI top-700 Index, Japanese companies with outstanding ESG evaluations are selected.

<FTSE Russell>

• -FTSE4Good Index Series (5 consecutive years from 2018)

  This international index is designed by FTSE Russell, a member of the London Stock Exchange group. Companies with relatively excellent ESG practices are selected in each sector.

• -FTSE Blossom Japan Index series (5 consecutive years from 2018)

  This index is also designed by FTSE Russell. Japanese companies with excellent ESG practices are selected.

• -FTSE Blossom Japan Sector Relative Index (First in 2022)

  This index is also designed by FTSE Russell. Japanese companies with excellent ESG practices are selected. The Index is designed as a sector neutral benchmark and supports climate transitions to a low carbon economy, especially for those companies with particularly high GHG emissions, by evaluating companies’ climate governance and climate change efforts via the Transition Pathway Initiative’s Management Quality Score.

<Tokyo Stock Exchange and S&P Dow Jones Indices>

• -S&P/JPX Carbon Efficient Index (5 consecutive years from 2018)

  This index comprises companies included in the Tokyo Stock Price Index（TOPIX）, and the weight of constituent is determined by the disclosure status of environmental information and carbon efficiency (Carbon emissions per unit of revenue) based on market capitalization.

 “MSCI Japan ESG Select Leaders Index”, “FTSE Blossom Japan Index series”, “FTSE Blossom Japan Sector Relative Index”, and “S&P/JPX Carbon Efficient Index” are the ESG indices adopted as references for making its ESG investments by the Japanese Government Pension Investment Fund (GPIF), one of the world’s largest pension funds.

 Based on the corporate philosophy of “Dedicated to the Fight against Disease and Pain,” ONO continues to contribute to the sustainable development of society through the ESG perspective business activities and enhance sustainable corporate value.
 For details of the ONO group’s ESG initiatives, please refer to the following ONO’s Sustainability website: https://sustainability.ono-pharma.com/en